Current Status of COVID-19 Vaccines Rollout Nationwide: July 2022 Update for the Attorney General Community
On July 13, the U.S. reached over 222.6 million persons (67.1% of the total U.S. population) having received their primary COVID-19 vaccine series (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either the mRNA Pfizer/BioNTech or Moderna vaccines). Nearly 400,000 children under five years of age have…
Current Status of COVID-19 Vaccines Rollout Nationwide: June 2022 Update for the Attorney General Community
On June 17, the U.S. reached nearly 221.9 million persons (66.8% of the total U.S. population) having received their primary COVID-19 vaccine series (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either the mRNA Pfizer/BioNTech or Moderna vaccines). Over 104.7 million persons in the U.S. have received…
Current Status of COVID-19 Vaccines Rollout Nationwide: May 2022 Update for the Attorney General Community
On May 16, the U.S. reached nearly 220.6 million persons (66.4% of the total U.S. population) having received their primary COVID-19 vaccine series (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either the mRNA Pfizer/BioNTech or Moderna vaccines). Over 102 million persons in the U.S. have received…
Current Status of COVID-19 Vaccines Rollout Nationwide: March 2022 Update for the Attorney General Community
On March 24, the U.S. reached 255.1 million persons (76.8% of the total U.S. population) having received at least one dose of a COVID-19 vaccine and 217.3 million persons (65.4% of the total U.S. population) being fully vaccinated (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either…
Current Status of COVID-19 Vaccines Rollout Nationwide: February 2022 Update for the Attorney General Community
On February 18, the U.S. reached 252.5 million persons (76.1% of the total U.S. population) having received at least one dose of a COVID-19 vaccine and 214.5 million persons (64.6% of the total U.S. population) being fully vaccinated (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either…
Crisis Standards of Care During the COVID-19 Pandemic: Legal and Policy-Related Issues
As various regions of the the United States experienced COVID-19-related surges in cases, hospitals and other providers have reported scarcity in essential resources (e.g., available intensive care unit (ICU) beds, personnel, treatments, and personal protective equipment (PPE)). In response, providers as well as state, territorial, and local health authorities have prepared and/or implemented crisis standards…
Current Status of COVID-19 Vaccines Rollout Nationwide: January 2022 Update for the Attorney General Community
On January 18, the U.S. reached 249.4 million persons (75.1% of the total U.S. population) having received at least one dose of a COVID-19 vaccine and 209.3 million persons (63.0% of the total U.S. population) being fully vaccinated (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either…
NAAG Responds to FDA’s Comment Request on New Over-The-Counter Hearing Aid Rules
In response to a request for comments from the Food and Drug Administration (FDA) regarding new rules regulating over-the-counter hearing aids, NAAG submitted comments encouraging the FDA to take the below steps to ensure that states maintain a role as regulators in this emerging market: The FDA should define preemption terms in a way that…
Current Status of COVID-19 Vaccines Rollout Nationwide: December 2021 Update for the Attorney General Community
On December 20, the U.S. reached 241.6 million persons (72.8% of the total U.S. population) having received at least one dose of a COVID-19 vaccine and 203.9 million persons (61.4% of the total U.S. population) being fully vaccinated (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either…
Predatory and Unethical Practices in Substance Use Treatment, Part 1
The first training of this series addresses foundational concepts regarding substance use disorders, the treatment landscape, and relevant policy and legal considerations. Participants will also hear from people with lived experiences in navigating substance use treatment for themselves or loved ones including unethical, predatory, and fraudulent practices. The second training in this series, hosted on…
